Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × entinostat × Clear all

NCT01038778 2026-04-13

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Phase 1/2 Active not recruiting

47 enrolled 15 charts

Carcinoma, Renal Cell